Semaglutide, the drug found in Ozempic and Wegovy, was linked to nearly 40% fewer asthma attacks in a large real-world study.
The results: Only one — semaglutide, the active ingredient in drugs like Ozempic and Wegovy — made a difference. It was ...
Based on real-world records from the U.K., affected patients who went on any GLP-1 receptor agonist for a comorbid condition ...
The Cool Down on MSN
UK study suggests Ozempic, Wegovy users may have fewer asthma attacks
"Semaglutide also led to a 20% reduction in COPD flare-ups." ...
A large real-world study found semaglutide was associated with nearly 40% fewer asthma attacks and 20% fewer COPD flare-ups.
Morning Overview on MSN
Semaglutide users had nearly 40 percent fewer asthma attacks in a UK study
A drug best known for treating diabetes and driving weight loss may also be quietly helping the lungs. New research presented ...
The diabetes and weight-loss injection semaglutide can reduce asthma attacks by up to 40%, according to research presented at ...
Semaglutide and Asthma? The popular GLP-1 diabetes and weight-loss injection may be linked to fewer asthma attacks and COPD ...
Robust real-world data on the effectiveness of biologic therapies in children with severe asthma remain limited, particularly across different ages and early-life risk profiles. This evidence gap ...
People with asthma who started semaglutide, the drug sold as Ozempic and Wegovy, had nearly 40% fewer attacks than similar ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results